Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$1.76 - $2.83 $4.36 Million - $7.01 Million
2,477,172 Added 16329.41%
2,492,342 $6.31 Million
Q3 2023

Nov 14, 2023

BUY
$1.99 - $2.45 $30,188 - $37,166
15,170 New
15,170 $36,000
Q3 2022

Nov 14, 2022

SELL
$0.63 - $5.47 $232,413 - $2.02 Million
-368,911 Reduced 38.36%
592,794 $1.72 Million
Q2 2022

Aug 15, 2022

BUY
$4.27 - $8.26 $3.77 Million - $7.29 Million
882,393 Added 1112.56%
961,705 $4.35 Million
Q1 2022

May 16, 2022

BUY
$7.07 - $11.62 $438,127 - $720,091
61,970 Added 357.34%
79,312 $636,000
Q4 2021

Feb 14, 2022

BUY
$10.49 - $14.28 $181,917 - $247,643
17,342 New
17,342 $202,000

Others Institutions Holding SLGC

About SomaLogic, Inc.


  • Ticker SLGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 183,452,992
  • Description
  • SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...
More about SLGC
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.